Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Primary central nervous system lymphoma of the spinal cord: A LOC network cohort study.
Valyraki N, Ahle G, Tabouret E, Houot R, Jardin F, Ghesquières H, Schmitt A, Paillassa J, Choquet S, Soussain C, Ursu R, Nichelli L, Legarff-Tavernier M, Mathon B, Rozenblum L, Mokhtari K, Hoang-Xuan K, Houillier C. Valyraki N, et al. Among authors: tabouret e. Rev Neurol (Paris). 2024 Dec 19:S0035-3787(24)00662-3. doi: 10.1016/j.neurol.2024.11.003. Online ahead of print. Rev Neurol (Paris). 2024. PMID: 39706697
Tailoring glioblastoma treatment based on longitudinal analysis of post-surgical tumor microenvironment.
Bastiancich C, Snacel-Fazy E, Fernandez S, Robert S, Stacchini R, Plantureux L, Boissonneau S, Testud B, Guillet B, Debarbieux F, Luche H, Figarella-Branger D, Estève MA, Tabouret E, Tchoghandjian A. Bastiancich C, et al. Among authors: tabouret e. J Exp Clin Cancer Res. 2024 Nov 28;43(1):311. doi: 10.1186/s13046-024-03231-4. J Exp Clin Cancer Res. 2024. PMID: 39605004 Free PMC article.
EANO guideline on molecular testing of meningiomas for targeted therapy selection.
Sahm F, Bertero L, Brandner S, Capper D, Goldbrunner R, Jenkinson MD, Kalamarides M, Lamszus K, Albert NL, Mair MJ, Berghoff AS, Mawrin C, Wirsching HG, Maas SL, Raleigh DR, Reifenberger G, Schweizer L, Suwala AK, Tabatabai G, Tabouret E, Short S, Wen PY, Weller M, Le Rhun E, Wesseling P, van den Bent M, Preusser M. Sahm F, et al. Among authors: tabouret e. Neuro Oncol. 2024 Nov 22:noae253. doi: 10.1093/neuonc/noae253. Online ahead of print. Neuro Oncol. 2024. PMID: 39577862
Reappraisal of prognostic factors in CNS WHO grade 3 oligodendrogliomas IDH-mutant and 1p/19q co-deleted: lessons from the French POLA cohort.
Figarella-Branger D, Colin C, Mokhtari K, Uro-Coste E, Idbaih A, Appay R, Tabouret E, Touat M, Seyve A, Carpentier C, Dehais C, Ducray F; POLA network. Figarella-Branger D, et al. Among authors: tabouret e. Neuro Oncol. 2024 Oct 21:noae221. doi: 10.1093/neuonc/noae221. Online ahead of print. Neuro Oncol. 2024. PMID: 39432559
Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma.
Kacimi SEO, Dehais C, Feuvret L, Chinot O, Carpentier C, Bronnimann C, Vauleon E, Djelad A, Cohen-Jonathan Moyal E, Langlois O, Campone M, Ducloie M, Noel G, Cuzzubbo S, Taillandier L, Ramirez C, Younan N, Menei P, Dhermain F, Desenclos C, Ghiringhelli F, Bourg V, Ricard D, Faillot T, Appay R, Tabouret E, Nichelli L, Mathon B, Thomas A, Tran S, Bielle F, Alentorn A, Iorgulescu JB, Boëlle PY, Labreche K, Hoang-Xuan K, Sanson M, Idbaih A, Figarella-Branger D, Ducray F, Touat M; POLA Network. Kacimi SEO, et al. Among authors: tabouret e. J Clin Oncol. 2024 Oct 2:JCO2400049. doi: 10.1200/JCO.24.00049. Online ahead of print. J Clin Oncol. 2024. PMID: 39356975
Primary central nervous system lymphoma with initial spinal cord involvement (PCNSL-SC) is a rare entity: 4 case reports and review of literature.
Harlay V, Campello C, Bequet C, Petrirena G, Barrie M, Appay R, Arnoux I, Loosveld M, Testud B, Bertucci A, Tabouret E, Chinot O. Harlay V, et al. Among authors: tabouret e. Rev Neurol (Paris). 2024 Mar;180(3):224-229. doi: 10.1016/j.neurol.2023.10.003. Epub 2023 Oct 26. Rev Neurol (Paris). 2024. PMID: 39300797 Review. No abstract available.
SMAC mimetic drives microglia phenotype and glioblastoma immune microenvironment.
Snacel-Fazy E, Soubéran A, Grange M, Joseph K, Colin C, Morando P, Luche H, Pagano A, Brustlein S, Debarbieux F, Toutain S, Siret C, van de Pavert SA, Rougon G, Figarella-Branger D, Ravi VM, Tabouret E, Tchoghandjian A. Snacel-Fazy E, et al. Among authors: tabouret e. Cell Death Dis. 2024 Sep 15;15(9):676. doi: 10.1038/s41419-024-07056-z. Cell Death Dis. 2024. PMID: 39278921 Free PMC article.
Brain tumoroids: treatment prediction and drug development for brain tumors with fast, reproducible and easy-to-use personalized models.
Soubéran A, Jiguet-Jiglaire C, Toutain S, Morando P, Baeza-Kallee N, Appay R, Boucard C, Graillon T, Meyer M, Farah K, Figarella-Branger D, Tabouret E, Tchoghandjian A. Soubéran A, et al. Among authors: tabouret e. Neuro Oncol. 2024 Sep 10:noae184. doi: 10.1093/neuonc/noae184. Online ahead of print. Neuro Oncol. 2024. PMID: 39252580
Olaparib in recurrent isocitrate dehydrogenase mutant high-grade glioma: A phase 2 multicenter study of the POLA Network.
Esparragosa Vazquez I, Sanson M, Chinot OL, Fontanilles M, Rivoirard R, Thomas-Maisonneuve L, Cartalat S, Tabouret E, Appay R, Bonneville-Levard A, Darlix A, Meyronet D, Barritault M, Gueyffier F, Remontet L, Maucort-Boulch D, Honnorat J, Dehais C, Ducray F; POLA Network. Esparragosa Vazquez I, et al. Among authors: tabouret e. Neurooncol Adv. 2024 May 27;6(1):vdae078. doi: 10.1093/noajnl/vdae078. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 38855053 Free PMC article.
108 results